Nina Tolonen

2.6k total citations
24 papers, 1.3k citations indexed

About

Nina Tolonen is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Nina Tolonen has authored 24 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Nephrology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Nina Tolonen's work include Chronic Kidney Disease and Diabetes (11 papers), Diabetes Management and Research (10 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers). Nina Tolonen is often cited by papers focused on Chronic Kidney Disease and Diabetes (11 papers), Diabetes Management and Research (10 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers). Nina Tolonen collaborates with scholars based in Finland, Australia and Romania. Nina Tolonen's co-authors include Carol Forsblom, Per‐Henrik Groop, Lena M. Thorn, Johan Wadén, Markku Saraheimo, Daniel Gordin, Valma Harjutsalo, Laura Doglio, Sibylle Schleich and Jacomine Krijnse Locker and has published in prestigious journals such as Diabetes Care, Diabetes and Stroke.

In The Last Decade

Nina Tolonen

23 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nina Tolonen Finland	21	471	385	329	218	206	24	1.3k
Malcolm R. Ogborn Canada	24	190 0.4×	249 0.6×	61 0.2×	528 2.4×	165 0.8×	78	1.5k
Ali Ramezani United States	16	93 0.2×	409 1.1×	119 0.4×	300 1.4×	174 0.8×	24	1.7k
Krisztina Rusai Hungary	19	88 0.2×	159 0.4×	120 0.4×	111 0.5×	162 0.8×	48	1.1k
M. Burnier Switzerland	14	166 0.4×	104 0.3×	339 1.0×	30 0.1×	352 1.7×	27	1.2k
Norma Uribe Mexico	17	371 0.8×	273 0.7×	148 0.4×	31 0.1×	32 0.2×	35	1.2k
Elena Rampanelli Netherlands	20	157 0.3×	196 0.5×	47 0.1×	137 0.6×	219 1.1×	48	1.7k
Ling Guo United States	18	259 0.5×	45 0.1×	160 0.5×	56 0.3×	353 1.7×	39	1.3k
Wayde M. Weston United States	16	503 1.1×	87 0.2×	240 0.7×	84 0.4×	471 2.3×	26	1.6k

Countries citing papers authored by Nina Tolonen

Since Specialization

Citations

This map shows the geographic impact of Nina Tolonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nina Tolonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nina Tolonen more than expected).

Fields of papers citing papers by Nina Tolonen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nina Tolonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nina Tolonen. The network helps show where Nina Tolonen may publish in the future.

Co-authorship network of co-authors of Nina Tolonen

This figure shows the co-authorship network connecting the top 25 collaborators of Nina Tolonen. A scholar is included among the top collaborators of Nina Tolonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nina Tolonen. Nina Tolonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Panduru, Nicolae Mircea, Markku Saraheimo, Carol Forsblom, et al.. (2015). Urinary Adiponectin Is an Independent Predictor of Progression to End-Stage Renal Disease in Patients With Type 1 Diabetes and Diabetic Nephropathy. Diabetes Care. 38(5). 883–890. 32 indexed citations

Wadén, Johan, Carol Forsblom, Valma Harjutsalo, et al.. (2015). Leisure-time physical activity and development and progression of diabetic nephropathy in type 1 diabetes: the FinnDiane Study. Diabetologia. 58(5). 929–936. 43 indexed citations

Thorn, Lena M., Daniel Gordin, Valma Harjutsalo, et al.. (2015). The Presence and Consequence of Nonalbuminuric Chronic Kidney Disease in Patients With Type 1 Diabetes. Diabetes Care. 38(11). 2128–2133. 46 indexed citations

Panduru, Nicolae Mircea, Niina Sandholm, Carol Forsblom, et al.. (2015). Kidney Injury Molecule-1 and the Loss of Kidney Function in Diabetic Nephropathy: A Likely Causal Link in Patients With Type 1 Diabetes. Diabetes Care. 38(6). 1130–1137. 60 indexed citations

Feodoroff, Maija, Valma Harjutsalo, Carol Forsblom, et al.. (2015). Smoking and progression of diabetic nephropathy in patients with type 1 diabetes. Acta Diabetologica. 53(4). 525–533. 46 indexed citations

Tolonen, Nina, Carol Forsblom, Ville‐Petteri Mäkinen, et al.. (2014). Different Lipid Variables Predict Incident Coronary Artery Disease in Patients With Type 1 Diabetes With or Without Diabetic Nephropathy: The FinnDiane Study. Diabetes Care. 37(8). 2374–2382. 24 indexed citations

Gordin, Daniel, Carol Forsblom, Nicolae Mircea Panduru, et al.. (2014). Osteopontin Is a Strong Predictor of Incipient Diabetic Nephropathy, Cardiovascular Disease, and All-Cause Mortality in Patients With Type 1 Diabetes. Diabetes Care. 37(9). 2593–2600. 62 indexed citations

Thorn, Lena M., Carol Forsblom, Daniel Gordin, et al.. (2014). Different Risk Factor Profiles for Ischemic and Hemorrhagic Stroke in Type 1 Diabetes Mellitus. Stroke. 45(9). 2558–2562. 41 indexed citations

Forsblom, Carol, John L. Moran, Valma Harjutsalo, et al.. (2014). Added Value of Soluble Tumor Necrosis Factor-α Receptor 1 as a Biomarker of ESRD Risk in Patients With Type 1 Diabetes. Diabetes Care. 37(8). 2334–2342. 39 indexed citations

10.

Mäkinen, Ville‐Petteri, Pasi Soininen, Antti J. Kangas, et al.. (2013). Triglyceride‐cholesterol imbalance across lipoprotein subclasses predicts diabetic kidney disease and mortality in type 1 diabetes: the FinnDiane Study. Journal of Internal Medicine. 273(4). 383–395. 42 indexed citations

11.

Thomas, Merlin C., John L. Moran, Valma Harjutsalo, et al.. (2012). Hyperfiltration in type 1 diabetes: does it exist and does it matter for nephropathy?. Diabetologia. 55(5). 1505–1513. 27 indexed citations

12.

Tikellis, Chris, R. J. Pickering, Despina Tsorotes, et al.. (2012). Association of dietary sodium intake with atherogenesis in experimental diabetes and with cardiovascular disease in patients with Type 1 diabetes. Clinical Science. 124(10). 617–626. 17 indexed citations

13.

Gordin, Daniel, Johan Wadén, Carol Forsblom, et al.. (2011). Pulse Pressure Predicts Incident Cardiovascular Disease but Not Diabetic Nephropathy in Patients With Type 1 Diabetes (The FinnDiane Study). Diabetes Care. 34(4). 886–891. 30 indexed citations

14.

Forsblom, Carol, Valma Harjutsalo, Lena M. Thorn, et al.. (2011). Competing-Risk Analysis of ESRD and Death among Patients with Type 1 Diabetes and Macroalbuminuria. Journal of the American Society of Nephrology. 22(3). 537–544. 81 indexed citations

15.

Gordin, Daniel, Johan Wadén, Carol Forsblom, et al.. (2010). Arterial stiffness and vascular complications in patients with type 1 diabetes: The Finnish Diabetic Nephropathy (FinnDiane) Study. Annals of Medicine. 44(2). 196–204. 31 indexed citations

16.

Tolonen, Nina, Carol Forsblom, Lena M. Thorn, et al.. (2009). Lipid abnormalities predict progression of renal disease in patients with type 1 diabetes. Diabetologia. 52(12). 2522–2530. 58 indexed citations

17.

Thorn, Lena M., Carol Forsblom, Johan Wadén, et al.. (2009). Metabolic Syndrome as a Risk Factor for Cardiovascular Disease, Mortality, and Progression of Diabetic Nephropathy in Type 1 Diabetes. Diabetes Care. 32(5). 950–952. 90 indexed citations

18.

Mäkinen, Ville‐Petteri, Carol Forsblom, Lena M. Thorn, et al.. (2008). Metabolic Phenotypes, Vascular Complications, and Premature Deaths in a Population of 4,197 Patients With Type 1 Diabetes. Diabetes. 57(9). 2480–2487. 73 indexed citations

19.

Tolonen, Nina, Carol Forsblom, Lena M. Thorn, et al.. (2007). Relationship between lipid profiles and kidney function in patients with type 1 diabetes. Diabetologia. 51(1). 12–20. 34 indexed citations

20.

Tolonen, Nina, Laura Doglio, Sibylle Schleich, & Jacomine Krijnse Locker. (2001). Vaccinia Virus DNA Replication Occurs in Endoplasmic Reticulum-enclosed Cytoplasmic Mini-Nuclei. Molecular Biology of the Cell. 12(7). 2031–2046. 191 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Malcolm R. Ogborn Breakdown of academic impact, for papers by Ali Ramezani Breakdown of academic impact, for papers by Krisztina Rusai Breakdown of academic impact, for papers by M. Burnier Breakdown of academic impact, for papers by Norma Uribe Breakdown of academic impact, for papers by Elena Rampanelli Breakdown of academic impact, for papers by Ling Guo Breakdown of academic impact, for papers by Wayde M. Weston